| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 26, 2025 | Sale | $0.98 | 38,978 | 38,198 | 3,248,573 | Dec 01, 2025, 06:13 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 28, 2025 | Sale | $0.99 | 13,014 | 12,884 | 3,235,559 | Dec 01, 2025, 06:13 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Dec 01, 2025 | Sale | $0.94 | 39,096 | 36,750 | 3,196,463 | Dec 01, 2025, 06:13 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 21, 2025 | Sale | $0.83 | 41,287 | 34,268 | 3,371,840 | Nov 25, 2025, 06:05 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 24, 2025 | Sale | $0.98 | 56,992 | 55,852 | 3,314,848 | Nov 25, 2025, 06:05 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 25, 2025 | Sale | $0.92 | 27,297 | 25,113 | 3,287,551 | Nov 25, 2025, 06:05 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 20, 2025 | Sale | $0.89 | 26,411 | 23,506 | 3,413,127 | Nov 20, 2025, 05:52 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 18, 2025 | Sale | $0.93 | 33,776 | 31,412 | 3,482,104 | Nov 20, 2025, 05:52 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 19, 2025 | Sale | $0.94 | 42,566 | 40,012 | 3,439,538 | Nov 20, 2025, 05:52 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 13, 2025 | Sale | $0.98 | 58,372 | 57,205 | 3,592,061 | Nov 17, 2025, 07:23 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 14, 2025 | Sale | $0.93 | 39,560 | 36,791 | 3,552,501 | Nov 17, 2025, 07:23 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 17, 2025 | Sale | $0.95 | 36,621 | 34,790 | 3,515,880 | Nov 17, 2025, 07:23 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 12, 2025 | Sale | $1.09 | 26,101 | 28,450 | 3,650,433 | Nov 12, 2025, 07:49 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 07, 2025 | Sale | $1.11 | 43,950 | 48,785 | 3,743,524 | Nov 12, 2025, 07:49 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 10, 2025 | Sale | $1.18 | 31,172 | 36,783 | 3,712,352 | Nov 12, 2025, 07:49 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 11, 2025 | Sale | $1.14 | 35,818 | 40,833 | 3,676,534 | Nov 12, 2025, 07:49 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 05, 2025 | Sale | $1.22 | 30,774 | 37,544 | 3,822,421 | Nov 06, 2025, 07:43 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 06, 2025 | Sale | $1.21 | 34,947 | 42,286 | 3,787,474 | Nov 06, 2025, 07:43 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 04, 2025 | Sale | $1.22 | 90,164 | 110,000 | 3,853,195 | Nov 06, 2025, 07:43 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Oct 30, 2025 | Sale | $1.43 | 55,795 | 79,787 | 4,076,920 | Nov 03, 2025, 07:11 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Oct 31, 2025 | Sale | $1.28 | 73,192 | 93,686 | 4,003,728 | Nov 03, 2025, 07:11 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Nov 03, 2025 | Sale | $1.29 | 60,369 | 77,876 | 3,943,359 | Nov 03, 2025, 07:11 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Oct 29, 2025 | Sale | $1.55 | 86,154 | 133,539 | 4,132,715 | Oct 29, 2025, 07:22 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Oct 27, 2025 | Sale | $1.72 | 46,664 | 80,262 | 4,263,196 | Oct 29, 2025, 07:22 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Oct 28, 2025 | Sale | $1.64 | 44,327 | 72,696 | 4,218,869 | Oct 29, 2025, 07:22 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Mar 27, 2025 | Sale | $1.05 | 2,425 | 2,546 | 4,309,860 | Apr 30, 2025, 04:09 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Mar 27, 2025 | ATM/ITM Option Exercise | $0.09 | 28,113 | 2,530 | 4,312,285 | Apr 30, 2025, 04:09 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | May 04, 2021 | Conversion | - | 3,671,965 | - | 4,133,373 | May 06, 2021, 04:19 PM |
| HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | May 04, 2021 | Buy | $16.00 | 150,799 | 2,412,784 | 4,284,172 | May 06, 2021, 04:19 PM |
| SNDX | | Syndax Pharmaceuticals Inc | Luke Evnin | Director | Mar 08, 2016 | Conversion | - | 2,168,691 | - | 2,168,691 | Mar 08, 2016, 06:37 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Jun 13, 2013 | Sale | $30.07 | 20,311 | 610,843 | 0 | Jun 13, 2013, 03:52 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Jun 12, 2013 | Sale | $30.00 | 2,435 | 73,050 | 20,311 | Jun 13, 2013, 03:52 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Jun 03, 2013 | Sale | $30.00 | 82,072 | 2,462,160 | 824,255 | Jun 04, 2013, 12:41 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 30, 2013 | Sale | $30.00 | 44,582 | 1,337,460 | 916,262 | Jun 03, 2013, 04:04 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 31, 2013 | Sale | $30.00 | 9,935 | 298,050 | 906,327 | Jun 03, 2013, 04:04 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 29, 2013 | Sale | $30.00 | 20,411 | 612,330 | 960,844 | May 30, 2013, 02:47 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 28, 2013 | Sale | $30.95 | 195,117 | 6,039,523 | 1,061,535 | May 30, 2013, 02:47 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 22, 2013 | Sale | $30.00 | 7,340 | 220,200 | 1,176,372 | May 23, 2013, 05:48 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | May 20, 2013 | Sale | $30.00 | 13,550 | 406,500 | 1,183,712 | May 21, 2013, 01:44 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 12, 2013 | Sale | $29.30 | 3,416 | 100,089 | 1,314,255 | May 08, 2013, 12:55 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 12, 2013 | ATM/ITM Option Exercise | $2.69 | 37,192 | 100,046 | 1,317,671 | May 08, 2013, 12:55 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 24, 2013 | Sale | $30.04 | 6,303 | 189,342 | 1,163,486 | Apr 29, 2013, 04:50 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 23, 2013 | Sale | $30.00 | 108,115 | 3,243,450 | 1,169,789 | Apr 29, 2013, 04:50 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 12, 2013 | Sale | $30.00 | 10,000 | 300,000 | 1,280,479 | Apr 18, 2013, 05:10 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Apr 15, 2013 | Sale | $30.00 | 2,575 | 77,250 | 1,277,904 | Apr 18, 2013, 05:10 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Mar 18, 2013 | Sale | $28.44 | 500,000 | 14,220,000 | 2,290,479 | Mar 19, 2013, 03:25 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Mar 11, 2013 | Sale | $27.86 | 500,000 | 13,930,000 | 2,790,479 | Mar 13, 2013, 12:29 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Nov 21, 2011 | Buy | $6.50 | 461,538 | 2,999,997 | 3,290,479 | Nov 22, 2011, 01:58 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Feb 08, 2011 | Conversion | - | 2,200,247 | - | 2,293,227 | Feb 17, 2011, 02:57 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Feb 08, 2011 | Buy | $7.00 | 535,714 | 3,749,998 | 2,828,941 | Feb 17, 2011, 02:57 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Feb 08, 2012 | Conversion | - | 2,200,247 | - | 2,293,227 | Feb 10, 2011, 04:21 PM |
| PCRX | | Pacira Pharmaceuticals, Inc. | Luke Evnin | Director | Feb 08, 2012 | Buy | $7.00 | 535,714 | 3,749,998 | 2,828,941 | Feb 10, 2011, 04:21 PM |
| PIP | | PHARMATHENE, INC | Luke Evnin | 10% Owner | Nov 03, 2010 | Conversion | $2.54 | 2,428,171 | 6,171,682 | 5,917,614 | Nov 05, 2010, 03:59 PM |
| PIP | | PHARMATHENE, INC | Luke Evnin | 10% Owner | Nov 03, 2010 | Buy | $3.50 | 430,000 | 1,505,000 | 6,347,614 | Nov 05, 2010, 03:59 PM |